Source: Vascular Pharmacology. Unidade: FMRP
Subjects: HIPERTENSÃO, METALOPROTEINASES, ESTRESSE OXIDATIVO, POLIPEPTÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MELLO, Marcela M. Blascke de et al. Matrix metalloproteinase (MMP)-2 activation by oxidative stress decreases aortic calponin-1 levels during hypertrophic remodeling in early hypertension. Vascular Pharmacology, v. 116, p. 36-44, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.vph.2018.10.002. Acesso em: 10 nov. 2024.APA
Mello, M. M. B. de, Parente, J. M., Schulz, R., & Castro, M. M. de. (2019). Matrix metalloproteinase (MMP)-2 activation by oxidative stress decreases aortic calponin-1 levels during hypertrophic remodeling in early hypertension. Vascular Pharmacology, 116, 36-44. doi:10.1016/j.vph.2018.10.002NLM
Mello MMB de, Parente JM, Schulz R, Castro MM de. Matrix metalloproteinase (MMP)-2 activation by oxidative stress decreases aortic calponin-1 levels during hypertrophic remodeling in early hypertension [Internet]. Vascular Pharmacology. 2019 ; 116 36-44.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.vph.2018.10.002Vancouver
Mello MMB de, Parente JM, Schulz R, Castro MM de. Matrix metalloproteinase (MMP)-2 activation by oxidative stress decreases aortic calponin-1 levels during hypertrophic remodeling in early hypertension [Internet]. Vascular Pharmacology. 2019 ; 116 36-44.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1016/j.vph.2018.10.002